HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
— Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung…
BlackLine Opens New Birmingham Office at 10 Brindleyplace